Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Ophthalmology StartUps and SMEs Financing

Australian Bionic Eye Developer Sets Sights To Enter Market By 2020

  • News

Executive Summary

Australia's Bionic Vision Technologies (BVT) has raised AUS$23m ($18m) from Hong Kong-based investors, China Huarong International Holdings Ltd and State Path Capital Limited, to develop and commercialize its retinal implant device. The technology could reach the market 3-5 years from now.

You may also be interested in...



Pixium's IRIS II CE Mark Stokes Retinal Implant Rivalry

Competition in the retinal implant market heats up as Pixium CE marks its second-generation bionic vision system, designed to offer key advantages including higher resolution and explantability.

Retina Implant Lengthens Headstart In Subretinal Implant Market

By CE-marking the Alpha AMS second-generation subretinal implant, Retina Implant has further widened the gap between itself and its rivals who are also developing devices to restore vision in patients blinded by degenerative retinal diseases such as retinitis pigmentosa.

Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio

Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.

Table

View full table

Topics

Related Companies

Tags:
Ophthalmology StartUps and SMEs Financing
Latest Headlines

German-Speaking European Associations Collaborate To Focus On Medtech’s Needs

US FDA Chief Scientist Bumpus Will Become Principal Deputy Commissioner

News We’re Watching: Biden Moves To Strengthen Supply Chain; More Medtech-Related Prosecutions; $5.5M Sepsis Grant For Siemens

FDA Receives Thousands Of Opinions On Proposal To Regulate LDTs As Comment Period Comes To A Close

See All
UsernamePublicRestriction

Register

MT104669

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By